Characteristics | n = 98 |
---|---|
Sex | |
Male | 63 (64.3%) |
Female | 35 (35.7%) |
Age (months) | |
At TICVAP insertion | 77.5 (18.0–144.0) |
At TICVAP removal | 109.5 (48.0–162.0) |
Body weight (kg) | |
At TICVAP insertion | 23.1 (12.5–41.1) |
At TICVAP removal | 32.0 (17.0–50.0) |
Indwell duration of TICVAP | |
Cumulative duration (days) | 32255 |
Median duration (months) | 12.5 (5.0–37.0) |
Body weight change during indwell (kg) | 4.0 (1.4–9.7) |
Follow-up duration (months) | 88.0 (45.0–100.0) |
Diagnosis | |
Hematologic | |
Acute leukemia | 31 (31.6%) |
Hemophilia | 3 (3.1%) |
Othersa | 8 (8.2%) |
Solid tumor | 35 (35.7%) |
Non-malignant | 11 (11.2%) |
Lymphoma | 10 (10.2%) |